Filing Details
- Accession Number:
- 0001209191-23-024058
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-04-11 19:55:00
- Reporting Period:
- 2023-01-27
- Accepted Time:
- 2023-04-11 19:55:00
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1788028 | Jasper Therapeutics Inc. | JSPR | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1242126 | Mark Mcdade | C/O Qiming U.s. Ventures Management, Llc 11100 Ne 8Th St., Suite 200 Bellevue WA 98004 | No | No | Yes | No | |
| 1248153 | E Gary Rieschel | C/O Qiming U.s. Ventures Management, Llc 11100 Ne 8Th St., Suite 200 Bellevue WA 98004 | No | No | Yes | No | |
| 1765710 | Qiming U.s. Healthcare Fund Ii, L.p. | 11100 Ne 8Th St., Suite 200 Bellevue WA 98004 | No | No | Yes | No | |
| 1868862 | Qiming U.s. Healthcare Gp Ii, Llc | 11100 Ne 8Th St., Suite 200 Bellevue WA 98004 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Voting Common Stock | Acquisiton | 2023-01-27 | 2,666,666 | $1.50 | 8,519,648 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The securities are directly held by Qiming U.S. Healthcare Fund II, L.P. ("Qiming"). The general partner of Qiming is Qiming U.S. Healthcare GP II, LLC ("Qiming GP"). Gary Rieschel and Mark McDade are the managing partners of Qiming GP and may be deemed to share voting and dispositive power over the shares held by Qiming. Each of Qiming GP and Messrs. Rieschel and McDade disclaims beneficial ownership of such shares except to the extent of its or his pecuniary interest therein.
Billionaire Hedge Funds
